314
A case series of the removal of large sialoliths from the hilum
of the submandibular gland via a transoral approach
E. Stiles
∗
, S. Jones
Royal Gwent Hospital, Newport, Cardiff, United Kingdom
Background:
There are several treatment options for patients pre-
senting with sialoliths in the submandibular gland. These include
sialadenectomy of the gland, basket retrieval, lithotripsy, and tran-
soral removal.
For sialoliths not amenable to basket retrieval or lithotripsy,
generally those situatedmore proximally or at the hilumof the duct
and larger than 7 mm in size, sialadenectomy, complete excision
of the gland, has been the traditional surgical treatment of choice.
This is associatedwith postsurgical morbidities including scarring,
lower lip weakness, altered sensation, and often a prolonged stay
in hospital. These can significantly affect patient experience and
postoperative quality of life.
Objective:
We present a case series of three patients who pre-
sented to a district hospital in south Wales, United Kingdom, with
symptomatic sialoliths at the hilum of the submandibular gland
requiring removal.
Method:
Three patients had sialoliths removed using the transoral
surgical technique under general anaesthetic. The sialoliths were
deemed unsuitable for basket retrieval or lithotripsy as they were
situated at the hilum of the submandibular duct.
Findings:
All three patients had sialoliths safely and successfully
removed. On review six months postoperatively, their symptoms
had completely resolved and there were no residual morbidities
associated with submandibular gland excision.
Conclusion:
Transoral removal of larger sialoliths unsuitable for
lithotripsy may be an effective, viable procedure for gland preser-
vation and reduction of postoperative morbidity. This can be
performed under general anaesthetic as a cost-effective short-stay
procedure in a district general hospital.
http://dx.doi.org/10.1016/j.ijom.2017.02.1057Xerostomia in Crohn’s disease
C.X.W. Tan
∗
, S. de Vries, K.H.N. de Boer, H.S. Brand,
T. Forouzanfar
VU Medical Centre, Amsterdam, The Netherlands
Background:
Crohn’s disease has several oral manifestations
including xerostomia and other non-specific oral symptoms.
Objectives:
To determine the relation between Crohn’s disease
activity and xerostomia. Furthermore, the salivary flow rate will
be determined to distinguish a dry mouth experience from actual
salivary gland hypofunction. Additionally, the frequency of some
non-specific oral symptoms and their correlation with disease
activity was explored.
Methods:
53 consecutive patients with Crohn’s disease in a ter-
tiary referral hospital were included. Primary outcomes were the
xerostomia inventory (XI)-score, the salivary flow rate and oral
and dental complaints. Disease activity was determined with the
Harvey Bradshaw Index (HBI) and the shortened version of the
Inflammatory Bowel Disease Questionnaire (IBDQ-9).
Findings:
Mean XI-score in patients with Crohn’s disease
was 25.4
±
8.6. XI-scores correlated significantly with the
IBDQ-scores (
r
=
−
0.352,
P
= 0.010), but not to the HBI-scores
(
r
= 0.137,
P
= 0.328). No significant correlation was found
between saliva secretion rates and disease activity. Significant cor-
relations were found between the XI-score and oral (
r
= 0.554,
P
< 0.001) and dental complaints (
r
= 0.372,
P
= 0.008). The num-
ber of oral complaints correlated with disease activity (HBI:
r
=
−
0.349,
P
= 0.011; IBDQ:
r
= 0.403,
P
= 0.003). Patients with
lower IBDQ-9 scores experienced more temporomandibular joint
complaints (OR 8.76, 1.01–76.08) and angular cheilitis (OR 5.69,
1.38–23.39).
Conclusions:
Patients with Crohn’s disease experience more
severe xerostomia. Xerostomia is not related to clinical disease
activity, but associated with disease activity associated quality
of life. Patients experiencing xerostomia do not necessarily have
reduced saliva secretion rates. Oral complaints are more frequent
in patients, especially during active disease.
http://dx.doi.org/10.1016/j.ijom.2017.02.1058Epithelial–myoepithelial carcinoma of the palate: our
experience
C.C. Tan
∗
, L.O. Aung, G.K. Thomas
Department of Oral and Maxillofacial Clinical Sciences, Faculty
of Dentistry, University of Malaya, Kuala Lumpur, Malaysia
Epithelial–myoepithelial carcinoma arising in the palate is rare. It
comprises about 1% of all salivary gland tumours. This is a case
of 38-year-old Chinese lady with painless slow growing palatal
swelling of six months duration. The 2 cm diameter nodular mass
located at the hard palate had a well-defined border with a central
ulcerated mucosa.
Computed tomography scan revealed palatal bony erosion.
Incisional biopsy was suggestive of benign pleomorphic ade-
noma of palate. Surgical wide excision of tumour was undertaken.
The microscopic findings confirmed the diagnosis of epithelial-
myoepithelial carcinoma of palate upon the immunostaining with
S100, EMA, GFAP, p63 and MNF 116. This report describes the
clinical features, histopathology, differential diagnosis, relevant
prognostic factors and follow-up, which are extremely valuable in
management of such cases.
http://dx.doi.org/10.1016/j.ijom.2017.02.1059Plasmacytoma in the oral cavity — a case report
H.L. Tan
Oral and Maxillofacial Department, Faculty of Dentistry,
National University of Malaysia, Kuala Lumpur, Malaysia
Background:
Plasmacytoma refers to a discrete neoplastic plasma
cell tumour that proliferates within the soft tissue or skeletal bone.
The International Myeloma Working Group (2003) has divided it
based on the site of the tumour present. It may present in the bone as
solitary plasmacytoma of bone, in the soft tissue as extramedullary
plasmacytoma and multifocal systemic involvement as multiple
myeloma.
Objective:
The aim of this study is to report an extramedullary
plasmacytoma in the oral cavity.
Case Report:
A 38-year-old, Malay ethnic female presented to us
with progressive limitation of mouth opening and painful erythe-
matous ulcer over the left palate and retromolar region for the past




